Q32 Bio Inc. (QTTB) Profit Margin
Q32 Bio Inc. (QTTB) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2018-12-31 | -1044.29% |
| 2019-12-31 | -6237.45% |
| 2020-12-31 | -4762.92% |
| 2021-12-31 | -281.90% |
| 2022-12-31 | -1334.45% |
| 2023-12-31 | 808.04% |
| 2024-12-31 | N/A |
| 2025-12-31 | 55.46% |
How QTTB compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| KRYS | Krystal Biotech Inc. | 52.64% |
| UTHR | United Therapeutics Corporation | 41.94% |
| EXEL | Exelixis Inc. | 33.73% |
| VRTX | Vertex Pharmaceuticals Incorporated | 32.94% |
| LLY | Eli Lilly and Company | 31.67% |
These are five companies in the same sector as QTTB with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Q32 Bio Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("QTTB", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | QTTB | $15.15 | -1.43% | 0.31M |
| 3 | ||||
| 4 | ||||
| 5 |